NE
NexImmune
NEXI·NASDAQGaithersburg MDFounded 201120 employees
Micro CapbiotechPublicOncology
Platform: AIM nanopart
Market Cap
$0.01B
All Drugs
2
Clinical Trials
5
Failed / Terminated
2
FDA Approved
0
Stock Price & Catalysts (NEXI)
Loading NEXI stock data...
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Gelirasimod | NEX-9764 | Phase 3 | 3 | TNFα | WilmsSchizophrenia | ||
| Zorifotisoran | NEX-9634 | Preclinical | 2 | IL-23 | OCDPNH |
SEC Filings & Financial Documents
Insider Trading Activity
Fetching insider trading data from SEC EDGAR...
Catalyst Events (4)